Amsterdam, J. D. (2003-02). „A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder”. Journal of Clinical Psychiatry. 64 (2): 208—14. PMID12633131. doi:10.4088/JCP.v64n0216.Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Fowler, Joanna S. (1977). „2-Methyl-3-butyn-2-ol as an acetylene precursor in the Mannich reaction. A new synthesis of suicide inactivators of monoamine oxidase”. The Journal of Organic Chemistry. 42 (15): 2637—7. PMID874623. doi:10.1021/jo00435a026.
J. Hermann Nee Voeroes, Z. Ecsery, G. Sabo, L. Arvai, L. Nagi, O. Orban, E. Sanfai, U.S. Patent 4.564.706 (1986)
nih.gov
ncbi.nlm.nih.gov
Amsterdam, J. D. (2003-02). „A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder”. Journal of Clinical Psychiatry. 64 (2): 208—14. PMID12633131. doi:10.4088/JCP.v64n0216.Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Fowler, Joanna S. (1977). „2-Methyl-3-butyn-2-ol as an acetylene precursor in the Mannich reaction. A new synthesis of suicide inactivators of monoamine oxidase”. The Journal of Organic Chemistry. 42 (15): 2637—7. PMID874623. doi:10.1021/jo00435a026.
psychiatrymmc.com
Cascade EF, Kalali AH (2007). „EMSAM: The First Year”. Psychiatry 2007. Архивирано из оригинала 28. 02. 2010. г. Приступљено 30. 11. 2009.
web.archive.org
Cascade EF, Kalali AH (2007). „EMSAM: The First Year”. Psychiatry 2007. Архивирано из оригинала 28. 02. 2010. г. Приступљено 30. 11. 2009.